These benefits, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 aid the notion of concentrating on ACKR3 as a unique method to modulate the opioid system, which could open new therapeutic avenues for opioid-linked Diseases. A study review released in https://grahamy692wto9.wikigdia.com/user